Rx (Prescription Medicine)
USD $ 56.00
Daslemia 70mg Tablet 是一种主要用于治疗特定类型癌症的药物。其活性成分是一种靶向治疗剂，旨在干扰癌细胞的生长与扩散。Daslemia 通过抑制对癌细胞增殖和存活至关重要的特定蛋白来发挥作用。这种靶向作用有助于减缓或停止疾病的进展。它通常由医疗专业人员为被诊断患有某些恶性疾病的患者开具处方，常作为包括手术、放射治疗或其他化疗药物在内的综合治疗方案的一部分。
Daslemia 70mg Tablet 的推荐剂量和用法应严格遵医嘱。通常口服服用。常见的不良反应可能包括疲劳、恶心、腹泻、皮疹以及血细胞计数的变化。如出现持续或严重的不良反应，请立即向医生报告。Daslemia 应储存在室温下，远离潮湿和直接热源，并置于儿童不易触及的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Dasatinib 70 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
